Sionna Therapeutics, Inc. Common Stock (SION : NASDAQ)
Common Stock
$7.04
USD
+0.00 (%)
Last updated: 2026-09-17
Get SION alerts:
SION
Sionna Therapeutics, Inc. Common Stock
WealthAwesomePerformance
1 Day
+2.33%
1 Week
-5.88%
1 Month
+19.12%
YTD
-80.83%
Key Statistics
Market Cap
$317.86M
52W High
$54.97
52W Low
$4.01
P/E Ratio
-
50 Day MA
$25.54
200 Day MA
$36.12
Beta
-
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $7.27 | $7.73 | $7.15 | $7.18 | $7.18 | 1,476,001 |
| 9/16/2026 | $6.95 | $7.37 | $6.91 | $7.04 | $7.04 | 1,969,702 |
| 9/15/2026 | $7.87 | $8.00 | $6.85 | $6.88 | $6.88 | 2,462,370 |
| 9/14/2026 | $7.84 | $8.54 | $7.84 | $8.26 | $8.26 | 1,218,419 |
| 9/11/2026 | $7.79 | $8.03 | $7.47 | $7.85 | $7.85 | 1,210,909 |
| 9/10/2026 | $7.40 | $7.75 | $7.12 | $7.62 | $7.62 | 1,222,600 |
| 9/9/2026 | $7.27 | $7.55 | $7.17 | $7.48 | $7.48 | 766,100 |
| 9/8/2026 | $7.13 | $7.55 | $6.89 | $7.30 | $7.30 | 884,700 |
| 9/4/2026 | $6.68 | $7.22 | $6.62 | $7.18 | $7.18 | 921,800 |
| 9/3/2026 | $7.31 | $7.56 | $6.70 | $6.75 | $6.75 | 1,242,200 |
Analyst Price Targets
Based on 3 analysts covering SION · as of Sep 17, 2026
Wall Street analysts forecast SION stock price to rise 196.3% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$20.86
+196.3% Upside
Current Price
US$7.04
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SION's historical volatility
30-Day Vol
719.4%
Annualized
90-Day Vol
497.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$6.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$6.77 | US$0.57 – US$80.96 |
| 60 trading days | US$6.37 | US$0.19 – US$213.29 |
| 90 trading days | US$6.01 | US$0.08 – US$442.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sionna Therapeutics, Inc. Common Stock
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; SION-451, which is nucleotide-binding domain 1 stabilizer in Phase 1 trial; and SION-719, which is nucleotide-binding domain 1 stabilizer in Phase 2a proof-of-concept trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-108.84M
- Profit Margin
- 0.00%
- ROE (TTM)
- -32.34%
- EPS (Diluted)
- -2.21
- Book Value
- 5.88
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SION.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |